Clinical Trials List
Protocol NumberMK-4482-002
NCT Number(ClinicalTrials.gov Identfier)-
2021-06-25 - 2022-09-13
Phase II/III
Recruiting2
-
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/09/23
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Principal Investigator
Shan-Chwen Chang
Co-Principal Investigator
- Wang-Huei Sheng Division of Infectious Disease
- 陳抱宇 Division of Infectious Disease
- 劉旺達 Division of Infectious Disease
- 李建璋 Division of Emergency Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
-
Objectives
-
Test Drug
-
Active Ingredient
-
Dosage Form
-
Dosage
-
Endpoints
-
Inclution Criteria
-
Exclusion Criteria
-
The Estimated Number of Participants
-
Taiwan
32 participants
-
Global
1850 participants
